Progressive approval: A proposal for a new regulatory pathway for regenerative medicine

Stem Cells Translational Medicine

Volumn 3, Issue 5, 2014, Pages 560-563

  Caplan, Arnold I ^a   West, Michael D ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BIOTIME INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT;

ARTICLE; BIOLOGICAL THERAPY; EMBRYONIC STEM CELL; GOVERNMENT REGULATION; HEALTH CARE QUALITY; LEGAL ASPECT; MARKETING; MESENCHYMAL STEM CELL; PACKAGING; PLURIPOTENT STEM CELL; POLICY; PRODUCT SAFETY; PROGRESSIVE APPROVAL; REGENERATIVE MEDICINE; THERAPY APPROVAL;

BIOMEDICAL RESEARCH; HUMANS; REGENERATIVE MEDICINE;

EID: 84899700962     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0180     Document Type: Article

References (0)